Developer docs
API playgroundTry for free, no card

Search company profiles

Omega Diagnostics

Full company profile

uuid003vpvu

Namestring
Omega Diagnostics
Legal namestring
Omega Diagnostics Ltd
Company typeenum
Public
Founded yearint
1987
Descriptiontext

Omega Diagnostics Ltd is a UK-based in-vitro diagnostics (IVD) company operating as a subsidiary of Cambridge Nutritional Sciences Plc within the publicly listed Omega Diagnostics Group PLC (LSE: ODX). Founded in 1987 and headquartered in Littleport, Cambridgeshire, with an additional office in Mumbai (Omega Dx (Asia) Pvt Ltd), the company develops, manufactures, and markets immunoassay-based diagnostic products for food sensitivity and gut health. Its core portfolio consists of two complementary products: FoodPrint®, a laboratory-based IgG food sensitivity testing platform that processes serum/plasma samples, and Food Detective®, a point-of-care test designed for in-clinic use by practitioners.

The company’s technology stack combines wet-lab immunoassay chemistry with a digital results delivery layer. Samples submitted to the laboratory are processed under a LIMS aligned with Royal College of Pathologists Guidelines, and results are delivered to practitioners and patients through the Omega Digital Platform — a web, iOS and Android application built and hosted by Cirdan on Microsoft Azure servers located in the United Kingdom. Omega controls the underlying data while Cirdan manages the technology infrastructure.

Commercially, Omega generates revenue through one-time sales of diagnostic test kits and recurring laboratory processing services, supported by a direct-to-practitioner website (omegadx.com), a direct-to-consumer e-commerce storefront (cnslab.co.uk, Magento-based), and a distributor network spanning 63 countries. Its primary customers are healthcare practitioners in functional medicine, nutrition and dietetics, with consumers reached both via practitioner referral and direct purchase. The company has invested in geographic expansion (notably India), digital platform capabilities, and event-driven demand generation (e.g., WHX Labs Dubai 2026), while restructuring away from pandemic-era COVID-19 test manufacturing.

Short descriptiontext

Omega Diagnostics is a UK-based IVD company that develops and sells immunoassay-based food sensitivity and gut health tests (FoodPrint® and Food Detective®) to healthcare practitioners and consumers across 63 countries, with lab processing and digital results delivered via its Omega Digital Platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLittleport, United Kingdom
HQ citystring
Littleport
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
food sensitivity testing, in-vitro diagnostics, IgG immunoassay tests, gut health diagnostics, functional medicine tests
Industry2 codes
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGADAN
Food, Feed & Nutraceutical Analytical Testing
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Testing Laboratories8734
Product category
In-vitro Diagnostics (Food Sensitivity & Gut Health)
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Diagnostic Product Sales
TypeOne Time License
Description

Sale of diagnostic test kits (FoodPrint and Food Detective) to healthcare practitioners and consumers. Products are sold directly via the company's e-commerce platform (cnslab.co.uk) and through a global distributor network spanning 63 countries.

omegadx.com
2Laboratory Processing Services
TypeSubscription Recurring
Description

Processing of patient serum and plasma samples in the company's laboratory to generate test results delivered via the Omega Digital Platform. Samples are collected via sample information forms and returned to the service laboratory. Revenue from lab processing is recurring as practitioners reorder tests for new and existing patients.

omegadx.com
3Digital Platform Services
TypeSubscription Recurring
Description

Subscription-style access to the Omega Digital Platform (web, iOS, Android) which delivers test results, reporting and analytics, and product recommendations to patients. Platform provided by Cirdan on Microsoft Azure.

businessinsider.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Diagnostic test kits and laboratory processing services — pricing not publicly available
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing is quote-based and not publicly disclosed. Transaction details are processed via PCI-DSS compliant payment gateway. The company also processes payments at point of receipt and at its head office for phone/seminar/exhibition transactions.

omegadx.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Food Detective®
Description

A diagnostic product for food sensitivity testing

omegadx.com
+2 more records
Core offering1 text field

Omega Diagnostics develops, manufactures, and markets in-vitro diagnostic (IVD) test kits for food sensitivity and gut health, anchored by two flagship products: FoodPrint®, a comprehensive laboratory food sensitivity testing platform that processes serum/plasma samples to detect IgG antibody reactions, and Food Detective®, a point-of-care test kit enabling in-clinic food sensitivity screening. The company also operates an in-house laboratory that processes practitioner- and patient-submitted samples and delivers results through the Omega Digital Platform (web, iOS, Android) provided by Cirdan and hosted on Microsoft Azure.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Omega Diagnostics is a health and nutrition diagnostics company that develops, manufactures, and markets diagnostic products primarily in the food sensitivity and gut health space. The company's core product portfolio consists of two main testing solutions: FoodPrint® and Food Detective®, both designed for use by healthcare practitioners to identify food sensitivities and intolerances through blood-based testing. These products enable practitioners to make informed decisions regarding personalized nutrition for their patients. Omega Diagnostics also previously manufactured COVID-19 tests (which were transitioned to a subcontractor) and CD4 production (relocated to Ely, Cambridgeshire). The company operates as a subsidiary of Cambridge Nutritional Sciences Plc.

Product and service3 records
1FoodPrint®
CategoryIn-vitro diagnostic test kit
Description

FoodPrint® is a laboratory-based food sensitivity testing platform that processes serum/plasma samples to detect IgG antibody reactions to a wide range of food antigens. Results are delivered to practitioners and patients through the Omega Digital Platform (web, iOS, Android). It is intended for use by healthcare practitioners to inform personalised nutrition recommendations.

2Food Detective®
CategoryIn-vitro diagnostic test kit
Description

Food Detective® is a point-of-care food sensitivity test kit that enables healthcare practitioners to screen patients for food-specific IgG antibody reactions in-clinic, delivering rapid results to guide dietary recommendations.

3Laboratory Sample Processing Services
CategoryDiagnostic laboratory services
Description

Sample processing service where practitioners and patients submit serum/plasma samples to Omega Diagnostics' in-house laboratory, which uses a Laboratory Information Management System (LIMS) aligned with Royal College of Pathologists Guidelines to generate test results delivered via the Omega Digital Platform.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or Integration
Description

Cirdan provides the Omega Digital Platform — a web platform, iOS and Android app that delivers test results directly to patients. Cirdan hosts the platform on Microsoft Azure servers in the United Kingdom. Omega controls the data while Cirdan manages the technology infrastructure.

2Cambridge Nutritional Sciences Plc
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Omega Diagnostics Ltd is a subsidiary of Cambridge Nutritional Sciences Plc, which is also the parent company (investor/holding structure). Cambridge Nutritional Sciences Plc is the parent entity and listed investor (cnsplc.com). Omega Diagnostics is described as an 'international diagnostics testing business' under the CNS group.

omegadx.com
Strategic tierMinorTypeOthers
Description

Shepherd & Wedderburn LLP provides registered office services for Omega Diagnostics Ltd at their Edinburgh address (9 Haymarket Square). This is a corporate registered office service arrangement.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Doctor's Data provides specialty functional-medicine testing (肠胃, toxins, hormones) used by integrative practitioners—a niche emerging peer that overlaps Omega's gut-health practitioner channel.

TypeBroad incumbent
Description

Eurofins operates a global food, feed, and nutraceutical analytical testing network, serving as a broad incumbent comparable to Omega's laboratory services arm and IVD testing for food-related health claims.

TypeDirect peer
Description

Cyrex Labs specialises in advanced immune reactivity and food sensitivity/sensitivity testing, serving functional and integrative medicine practitioners—directly comparable to Omega's immunoassay food sensitivity portfolio.

TypeBroad incumbent
Description

Bio-Rad is a diversified IVD and life science tools company with immunoassay and clinical diagnostics offerings relevant to Omega's IVD reagent core, representing a broader incumbent peer.

TypeBroad incumbent
Description

Thermo Fisher is a major IVD and immunoassay platform incumbent (Phadia/ImmunoCAP allergy diagnostics) with global distribution and clinical evidence capabilities well beyond Omega's, making it the dominant broad incumbent in overlapping food/allergy diagnostics.

TypeDirect peer
Description

Genova Diagnostics is a leading functional medicine laboratory offering IgG food sensitivity and comprehensive肠胃 diagnostics panels delivered to practitioners—a direct peer to Omega's FoodPrint lab-based offering.

7Cambridge Nutritional Sciences PLC
TypeOthers
Description

CNS is Omega Diagnostics' parent company and the listed entity under which Omega operates; together they share the same food sensitivity testing portfolio and practitioner base, making CNS the closest group-level comparator.

TypeDirect peer
Description

Vibrant Wellness provides food sensitivity and gut-health testing through practitioner channels, with a digital results and recommendation platform—a direct competitor in functional-medicine food sensitivity diagnostics.

TypeDirect peer
Description

Alletess offers IgG and IgE food sensitivity/sensitivity panels for healthcare practitioners, competing head-to-head with FoodPrint in the practitioner-ordered food sensitivity segment.

10Abbott Diagnostics
TypeBroad incumbent
Description

Abbott is a leading broad IVD incumbent with immunoassay platforms, allergy testing, and global distribution; it serves as a broad incumbent benchmark for what a scaled IVD reagent and platform competitor could become in food sensitivity adjacency.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Omega Diagnostics

In-vitro Diagnostics (Food Sensitivity & Gut Health)omegadiagnostics.com

Omega Diagnostics is a UK-based IVD company that develops and sells immunoassay-based food sensitivity and gut health tests (FoodPrint® and Food Detective®) to healthcare practitioners and consumers across 63 countries, with lab processing and digital results delivered via its Omega Digital Platform.

What Omega Diagnostics does

Omega Diagnostics Ltd is a UK-based in-vitro diagnostics (IVD) company operating as a subsidiary of Cambridge Nutritional Sciences Plc within the publicly listed Omega Diagnostics Group PLC (LSE: ODX). Founded in 1987 and headquartered in Littleport, Cambridgeshire, with an additional office in Mumbai (Omega Dx (Asia) Pvt Ltd), the company develops, manufactures, and markets immunoassay-based diagnostic products for food sensitivity and gut health. Its core portfolio consists of two complementary products: FoodPrint®, a laboratory-based IgG food sensitivity testing platform that processes serum/plasma samples, and Food Detective®, a point-of-care test designed for in-clinic use by practitioners.

The company’s technology stack combines wet-lab immunoassay chemistry with a digital results delivery layer. Samples submitted to the laboratory are processed under a LIMS aligned with Royal College of Pathologists Guidelines, and results are delivered to practitioners and patients through the Omega Digital Platform — a web, iOS and Android application built and hosted by Cirdan on Microsoft Azure servers located in the United Kingdom. Omega controls the underlying data while Cirdan manages the technology infrastructure.

Commercially, Omega generates revenue through one-time sales of diagnostic test kits and recurring laboratory processing services, supported by a direct-to-practitioner website (omegadx.com), a direct-to-consumer e-commerce storefront (cnslab.co.uk, Magento-based), and a distributor network spanning 63 countries. Its primary customers are healthcare practitioners in functional medicine, nutrition and dietetics, with consumers reached both via practitioner referral and direct purchase. The company has invested in geographic expansion (notably India), digital platform capabilities, and event-driven demand generation (e.g., WHX Labs Dubai 2026), while restructuring away from pandemic-era COVID-19 test manufacturing.

Omega Diagnostics firmographics

Firmographics
Name
Omega Diagnostics
Legal name
Omega Diagnostics Ltd
Website
https://omegadiagnostics.com
Company type
Public
Founded year
1987
Operating status
Operating
Headcount range
51–100 employees
Short description
Omega Diagnostics is a UK-based IVD company that develops and sells immunoassay-based food sensitivity and gut health tests (FoodPrint® and Food Detective®) to healthcare practitioners and consumers across 63 countries, with lab processing and digital results delivered via its Omega Digital Platform.
Ownership category
akta.pro rank

Omega Diagnostics industry classification

Industry
Product category
In-vitro Diagnostics (Food Sensitivity & Gut Health)
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGADAN
Food, Feed & Nutraceutical Analytical Testing

Keywords

  • Food sensitivity testing
  • In-vitro diagnostics
  • IgG immunoassay tests
  • Gut health diagnostics
  • Functional medicine tests

Where Omega Diagnostics is headquartered

Location

Headquarters

HQ city
Littleport
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Omega Diagnostics business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Diagnostic Product Sales: Sale of diagnostic test kits (FoodPrint and Food Detective) to healthcare practitioners and consumers. Products are sold directly via the company's e-commerce platform (cnslab.co.uk) and through a global distributor network spanning 63 countries.
  2. Laboratory Processing Services: Processing of patient serum and plasma samples in the company's laboratory to generate test results delivered via the Omega Digital Platform. Samples are collected via sample information forms and returned to the service laboratory. Revenue from lab processing is recurring as practitioners reorder tests for new and existing patients.
  3. Digital Platform Services: Subscription-style access to the Omega Digital Platform (web, iOS, Android) which delivers test results, reporting and analytics, and product recommendations to patients. Platform provided by Cirdan on Microsoft Azure.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goDiagnostic test kits and laboratory processing services — pricing not publicly available

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Omega Diagnostics product offering

Product offering

Core offering

Omega Diagnostics develops, manufactures, and markets in-vitro diagnostic (IVD) test kits for food sensitivity and gut health, anchored by two flagship products: FoodPrint®, a comprehensive laboratory food sensitivity testing platform that processes serum/plasma samples to detect IgG antibody reactions, and Food Detective®, a point-of-care test kit enabling in-clinic food sensitivity screening. The company also operates an in-house laboratory that processes practitioner- and patient-submitted samples and delivers results through the Omega Digital Platform (web, iOS, Android) provided by Cirdan and hosted on Microsoft Azure.

Product overview

Omega Diagnostics is a health and nutrition diagnostics company that develops, manufactures, and markets diagnostic products primarily in the food sensitivity and gut health space. The company's core product portfolio consists of two main testing solutions: FoodPrint® and Food Detective®, both designed for use by healthcare practitioners to identify food sensitivities and intolerances through blood-based testing. These products enable practitioners to make informed decisions regarding personalized nutrition for their patients. Omega Diagnostics also previously manufactured COVID-19 tests (which were transitioned to a subcontractor) and CD4 production (relocated to Ely, Cambridgeshire). The company operates as a subsidiary of Cambridge Nutritional Sciences Plc.

Differentiator

Problem solved

Functional benefit

Brands

  • Food Detective®: A diagnostic product for food sensitivity testing
  • FoodPrint®
  • Omega Digital Platform

Products and services

  • FoodPrint® FoodPrint® is a laboratory-based food sensitivity testing platform that processes serum/plasma samples to detect IgG antibody reactions to a wide range of food antigens. Results are delivered to practitioners and patients through the Omega Digital Platform (web, iOS, Android). It is intended for use by healthcare practitioners to inform personalised nutrition recommendations.
  • Food Detective® Food Detective® is a point-of-care food sensitivity test kit that enables healthcare practitioners to screen patients for food-specific IgG antibody reactions in-clinic, delivering rapid results to guide dietary recommendations.
  • Laboratory Sample Processing Services Sample processing service where practitioners and patients submit serum/plasma samples to Omega Diagnostics' in-house laboratory, which uses a Laboratory Information Management System (LIMS) aligned with Royal College of Pathologists Guidelines to generate test results delivered via the Omega Digital Platform.

Companies that use Omega Diagnostics

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Omega Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Omega Diagnostics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • CirdancoreTechnology or IntegrationCirdan provides the Omega Digital Platform — a web platform, iOS and Android app that delivers test results directly to patients. Cirdan hosts the platform on Microsoft Azure servers in the United Kingdom. Omega controls the data while Cirdan manages the technology infrastructure.
  • Cambridge Nutritional Sciences PlccoreStrategic or Co-development PartnerOmega Diagnostics Ltd is a subsidiary of Cambridge Nutritional Sciences Plc, which is also the parent company (investor/holding structure). Cambridge Nutritional Sciences Plc is the parent entity and listed investor (cnsplc.com). Omega Diagnostics is described as an 'international diagnostics testing business' under the CNS group.
  • Shepherd & Wedderburn LLPminorOthersShepherd & Wedderburn LLP provides registered office services for Omega Diagnostics Ltd at their Edinburgh address (9 Haymarket Square). This is a corporate registered office service arrangement.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Omega Diagnostics competitors and assessment

Company assessment

Emerging players

  • Doctor's Data: Doctor's Data provides specialty functional-medicine testing (肠胃, toxins, hormones) used by integrative practitioners—a niche emerging peer that overlaps Omega's gut-health practitioner channel.

Broad incumbents

  • Eurofins Scientific: Eurofins operates a global food, feed, and nutraceutical analytical testing network, serving as a broad incumbent comparable to Omega's laboratory services arm and IVD testing for food-related health claims.
  • Bio-Rad Laboratories: Bio-Rad is a diversified IVD and life science tools company with immunoassay and clinical diagnostics offerings relevant to Omega's IVD reagent core, representing a broader incumbent peer.
  • Thermo Fisher Scientific: Thermo Fisher is a major IVD and immunoassay platform incumbent (Phadia/ImmunoCAP allergy diagnostics) with global distribution and clinical evidence capabilities well beyond Omega's, making it the dominant broad incumbent in overlapping food/allergy diagnostics.
  • Abbott Diagnostics: Abbott is a leading broad IVD incumbent with immunoassay platforms, allergy testing, and global distribution; it serves as a broad incumbent benchmark for what a scaled IVD reagent and platform competitor could become in food sensitivity adjacency.

Direct peers

  • Cyrex Labs: Cyrex Labs specialises in advanced immune reactivity and food sensitivity/sensitivity testing, serving functional and integrative medicine practitioners—directly comparable to Omega's immunoassay food sensitivity portfolio.
  • Genova Diagnostics: Genova Diagnostics is a leading functional medicine laboratory offering IgG food sensitivity and comprehensive肠胃 diagnostics panels delivered to practitioners—a direct peer to Omega's FoodPrint lab-based offering.
  • Vibrant Wellness: Vibrant Wellness provides food sensitivity and gut-health testing through practitioner channels, with a digital results and recommendation platform—a direct competitor in functional-medicine food sensitivity diagnostics.
  • Alletess Medical Laboratory: Alletess offers IgG and IgE food sensitivity/sensitivity panels for healthcare practitioners, competing head-to-head with FoodPrint in the practitioner-ordered food sensitivity segment.

Others

  • Cambridge Nutritional Sciences PLC: CNS is Omega Diagnostics' parent company and the listed entity under which Omega operates; together they share the same food sensitivity testing portfolio and practitioner base, making CNS the closest group-level comparator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Omega Diagnostics social profiles

Digital presence

Omega Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Omega Diagnostics leadership team

Management profile

Number of profiles

Profiles5 records

Omega Diagnostics subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Omega Diagnostics funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Omega Diagnostics M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Omega Diagnostics

What does Omega Diagnostics do?

Omega Diagnostics develops, manufactures, and markets in-vitro diagnostic (IVD) test kits for food sensitivity and gut health, anchored by two flagship products: FoodPrint®, a comprehensive laboratory food sensitivity testing platform that processes serum/plasma samples to detect IgG antibody reactions, and Food Detective®, a point-of-care test kit enabling in-clinic food sensitivity screening. The company also operates an in-house laboratory that processes practitioner- and patient-submitted samples and delivers results through the Omega Digital Platform (web, iOS, Android) provided by Cirdan and hosted on Microsoft Azure.

Is Omega Diagnostics a public or private company?

Omega Diagnostics is a public company. It is classified as public and is currently operating.

When was Omega Diagnostics founded?

Omega Diagnostics was founded in 1987. It employs 51 to 100 people.

Where is Omega Diagnostics based?

Omega Diagnostics is headquartered in Littleport, United Kingdom, in the Europe region.

How does Omega Diagnostics make money?

Three revenue lines are on record. Diagnostic Product Sales are the primary driver. The others are laboratory Processing Services and digital Platform Services.

Who are Omega Diagnostics's main competitors?

Doctor's Data is listed as an emerging player. Broad incumbents are Eurofins Scientific, Bio-Rad Laboratories, Thermo Fisher Scientific and Abbott Diagnostics. Direct peers are Cyrex Labs, Genova Diagnostics, Vibrant Wellness and Alletess Medical Laboratory. Cambridge Nutritional Sciences PLC is listed as an others.

Does Omega Diagnostics have an API?

No public API is recorded for Omega Diagnostics.

What industry is Omega Diagnostics in?

Omega Diagnostics's product category is In-vitro Diagnostics (Food Sensitivity & Gut Health). Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAGADAN, Food, Feed & Nutraceutical Analytical Testing. Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business InsiderI applied for 900 jobs after being laid off at 62. AI made the search even harder.Jim Herrington, a 62-year-old former electronics marketer, applied for 900 positions after being laid off in 2024 before securing a role as marketing director at Omega Diagnostics. He criticizes the recruitment industry's reliance on AI screening and vague job descriptions, arguing these factors hinder candidates despite his eventual success. Herrington attributes his hire to his seniority and cross-industry experience, which Omega Diagnostics valued.MarketScreenerOmega Diagnostics finance director steps down with immediate effectOmega Diagnostics Group PLC said finance director Chris Lea stepped down with immediate effect, as the company focuses resources on its Ely, Cambridgeshire headquarters. The company plans to appoint an interim CFO and rebrand as Cambridge Nutritional Sciences at its upcoming AGM. Shares rose 3.7% to 2.70 pence.UK Investor MagazineOmega Diagnostics shares jump on positive VISITECT® dataOmega Diagnostics shares rose 18% after positive data from VISITECT CD4 Advanced Disease Rapid Test evaluations, showing 96% sensitivity. The company will receive an additional £4m if the test meets WHO pre-qualification requirements, with results expected in due course.Scotland NewsOmega Diagnostics announces preferred bidder for HIV testing kit divisionOmega Diagnostics agreed heads of terms with an anonymous bidder for its CD4 HIV testing business, expecting a significant up-front cash payment and a future royalty stream. The deal will leave the company focused on its health and nutrition division, with shares rising 6.4%.businessInsiderOmega Diagnostics sells Alva manufacturing business for £1 millionOmega Diagnostics agreed to sell its Alva diagnostic test kit manufacturing business to Accubio for £1m, with 109 employees transferring. The sale covers fixed assets and lease, with transitional arrangements for lateral flow tests until December 2022. Omega plans to move advanced disease test production to its new Ely site and adopt a sub-contract model for COVID-19 tests.BdailyLondon health and nutrition specialist raises £5m with plans for expansionOmega Diagnostics Group PLC, a London-based health and nutrition diagnostics company, raised gross proceeds of £5m by placing and subscribing 100 million new ordinary shares at 5 pence each. Net proceeds of between £4.6m and £6.6m will fund growth in its health and nutrition division, relocate CD4 production to a new facility in Ely, Cambridgeshire, and support a transition to a sub-contract model for COVID-19 testing.Scotland NewsOmega highlights allergy sales as Covid testing delays continueOmega Diagnostics reported a 97% sales rebound in its health and nutrition division for the first quarter, but total revenue fell to £8.7m and operating loss widened to £3.3m. The company's Covid testing contract with the DHSC remains uncertain, with the government yet to decide which test to produce.Scotland NewsOmega shares slip as decision delayed on which Covid test it will produceOmega Diagnostics shares fell nearly 4% after the UK government delayed deciding which Covid test the firm will manufacture under a contract. The deal could generate up to £374 million, and Omega has received £2.5 million in pre-production payments. The company remains in dialogue with the DHSC and expects to update shareholders once confirmed.Scotland NewsRapid Covid test from Omega stacks up well against ‘gold standard’ PCROmega Diagnostics' Mologic lateral flow antigen test detected the virus in 96.4% of PCR-positive cases, per independent verification by FIND. The study involved 665 self-collected swab samples in Germany. Omega plans to produce up to two million tests weekly for the UK government.Scotland NewsOmega to receive up to £374m from UK test dealOmega Diagnostics will receive up to £374 million from the UK government to manufacture rapid Covid-19 tests. The contract, with Global Access Diagnostics, targets 200 million antigen tests each, with capacity of two million per week by May. Headcount is expected to surpass 250 by next month.